Blood dyscrasias caused by hypersensitivity to drugs

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 306-320

  Aster Dr , Richard H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871686074     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104209     Document Type: Chapter

References (38)

1. Aster R: Drug-induced thrombocyto-penia; in Michelson A (ed): Platelets. New York, Academic Press, 2002,pp 593-606.
2. Aster RH: Drug-induced immune cyto-penias. Toxicology 2005; 209: 149-153.
3. Warkentin TE, Kelton JG: Thrombocy-topenia due to platelet destruction or hypersplenism; in Hoffman R, Benz EJ, Shattil SJ, et al (eds): Hematology: Basic Principles and Practice. Philadelphia, Churchill Livingstone, 2004, vol 4, pp 2305-2325.
4. George JN, Raskob GE, Shah SR, et al: Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998; 129: 886-890.
5. Kaufman DW, Kelly JP, Johannes CB, et al: Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993; 82: 2714-2718.
6. Christie DJ, Mullen PC, Aster RH: Fab-mediated binding of drug-dependent antibodies to platelets in quinidine-and quinine-induced thrombocytope-nia. J Clin Invest 1985; 75: 310-314.
7. Bougie DW, Wilker PR, Aster RH: Pa-tients with quinine-induced immune thrombocytopenia have both 'drug-dependent' and 'drug-specific' anti-bodies. Blood 2006; 108: 922-927.
8. Pichler WJ: Direct T-cell stimulations by drugs -bypassing the innate im-mune system. Toxicology 2005; 209: 95-100.
9. Reddy JC, Shuman MA, Aster RH: Qui-nine/quinidine-induced thrombocyto-penia: a great imitator. Arch Intern Med 2004; 164: 218-220.
10. Bougie D, Aster R: Immune thrombo-cytopenia resulting from sensitivity to metabolites of naproxen and acetamin-ophen. Blood 2001; 97: 3846-3850.
11. Aster RH: Can drugs cause autoim-mune thrombocytopenic purpura? Semin Hematol 2000; 37: 229-238.
12. Bougie DW, Wilker PR, Wuitschick ED, et al: Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002; 100: 2071-2076.
13. Artoni A, Li J, Mitchell B, et al: Integrin β3 regions controlling binding of mu-rine mAb 7E3: implications for the mechanism of integrin αIIbβ3 activa-tion. Proc Natl Acad Sci USA 2004; 101: 13114-13120.
14. Curtis BR, Divgi A, Garritty M, Aster RH: Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the im-mune response to the drug. J Thromb Haemost 2004; 2: 985-992.
15. Curtis BR, Swyers J, Divgi A, McFar-land JG, Aster RH: Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 2002; 99: 2054-2059.
16. Warkentin TE: An overview of the hep-arin-induced thrombocytopenia syn-drome. Semin Thromb Hemost 2004; 30: 273-283.
17. Davoren A, Aster RH: Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 2006; 81: 36-44.
18. Petz LD: Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 1993; 7: 242-254.
19. Rosse W: Autommune hemolytic ane-mia; in Handin RI, Lux SE, Stossel TP, et al (eds): Blood: Principles and Prac-tice of Hematology. Philadelphia,Lippincott, 1995, vol 1, pp 1819-1945.
20. Arndt PA, Garratty G: The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005; 42: 137-144.
21. Packham C: Hemolytic anemia result-ing from immune injury; in Lichtman M, Beutler E, Kipps TJ, et al (eds): Wil-liams Hematology. New York, McGraw-Hill, 2006, vol 7, pp 729-750.
22. Garratty G: Immune cytopenia associ-ated with antibiotics. Transfus Med Rev 1993; 7: 255-267.
23. Salama A, Mueller-Eckhardt C: The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985; 313: 469-474.
24. Cunha PD, Lord RS, Johnson ST, Wil-ker PR, Aster RH, Bougie DW: Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a non-ste-roidal anti-inflammatory drug. Trans-fusion 2000; 40: 663-668.
25. Kaufman DW, Kelly JP, Jurgelon JM: Drugs in the aetiology of agranulocyto-sis and aplastic anaemia. Eur J Haema-tol 1996; 60(suppl):55-59.
26. Van der Klauw MM, Wilson JH, Strick-er BH: Drug-associated agranulocyto-sis: 20 years of reporting in The Neth-erlands (1974-1994). Am J Hematol 1998; 57: 206-211.
27. Bhatt V, Saleem A: Review: Drug-in-duced neutropenia -pathophysiology, clinical features, and management. Ann Clin Lab Sci 2004; 34: 131-137.
28. Dale D: Neutropenia and neutrophilia; in Lichtman M, Beutler E, Kipps TJ, et al (eds): Williams Hematology. New York, McGraw-Hill, 2006, vol 7, pp 907-919.
29. IAAAS: Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special refer-ence to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 1986; 256: 1749-1757.
30. Stroncek DF: Drug-induced immune neutropenia. Transfus Med Rev 1993; 7: 268-274.
31. Dinauer MC, Coates TD: Disorders of phagocyte function and number; in Hoffman R, Benz EJ, Shattil SJ, et al (eds): Hematology: Basic Principles and Practice. Philadelphia, Churchill Liv-ingstone, 2005, vol 4, pp 787-829.
32. Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK: Induction of metabolism-dependent and -indepen-dent neutrophil apoptosis by clozapine. Mol Pharmacol 2000; 58: 207-216.
33. Guest I, Uetrecht J: Drugs that induce neutropenia/agranulocytosis may tar-get specific components of the stromal cell extracellular matrix. Med Hypoth 1999; 53: 145-151.
34. Stroncek DF, Herr GP, Maguire RB, Eiber G, Clement LT: Characterization of the neutrophil molecules identified by quinine-dependent antibodies from two patients. Transfusion 1994; 34: 980-985.
35. Fibbe WE, Claas FH, Van der Star-Dijk-stra W, Schaafsma MR, Meyboom RH, Falkenburg JH: Agranulocytosis in-duced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and hae-matopoietic progenitor cells. Br J Hae-matol 1986; 64: 363-373.
36. DeLoughery T: Drug-induced immune hematologic disease. Immunol Allergy Clin North Am 1998: 829-841.
37. Young NS: Aplastic anemia; in Hoff-man R, Benz EJ, Shattil SJ, et al (eds): Hematology: Basic Principles and Prac-tice. Philadelphia, Churchill Living-stone, 2004, vol 4, pp 381-417.
38. Siegel GB, Lichtman MA: Aplastic ane-mia; in Lichtman MA, Benz EJ, Kipps TJ, et al (eds): Williams Hematology. New York, McGraw-Hill, 2006, vol 7, pp 419-436.